Axol Bioscience
PrivateLast Round
Early Funding
Jan 13, 2026
Est. Valuation
$36.05M
Total Funding Raised
$17.01M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Axol Bioscience is a biotechnology company that provides human induced pluripotent stem cell (iPSC) technologies, specializing in the manufacture of iPSC-derived cells and the delivery of laboratory services for drug discovery and disease research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Axol Bioscience Comparables
Compare Axol Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ncardia | 90% | |
| iXCells Biotechnologies | 87% | |
| BrainXell | 85% | |
Axol Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jan 13, 2026 | ||||
| Grant | Dec 6, 2024 | ||||
| Series A Extension | Apr 7, 2022 | ||||
| Early Funding | Mar 16, 2021 | ||||
| Grant | Dec 1, 2020 | ||||
Private Equity | Aug 15, 2017 |
Key People
Founding team and executive leadership
Axol Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Par Equity | Series A Extension, Early Funding |
| European Commission | Grant |
| Meltwind Advisory | Series A Extension |
| Roslin Foundation | Early Funding |
| Calculus Capital | Private Equity, Series A Extension, Early Funding |
| Intuitive Investments Group | Early Funding |
| Scottish Investment Bank (Scottish Enterprise) | Early Funding, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 31, 2026
Partnering with ALS TDI and LifeArc on iPSC-derived motor neuron models.
- Mar 3, 2026
Developing a quantum-enabled brain-on-chip platform with multiple partners.
Axol Bioscience Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Axol Bioscience's valuation, stock price, and market status.